Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
u1K2amXLYVJ69UdK